• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于增强癌症治疗中mRNA递送的可逃逸至内体/溶酶体的脂质纳米颗粒平台

Endo/Lysosomal-Escapable Lipid Nanoparticle Platforms for Enhancing mRNA Delivery in Cancer Therapy.

作者信息

Wang Jiapeng, Chen Renjie, Xie Yongyi, Qin Xuanting, Zhou You, Xu Chuanshan

机构信息

Department of Medical Imageology, The Second Clinical College of Guangzhou Medical University, Guangzhou 511436, China.

State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, China.

出版信息

Pharmaceutics. 2025 Jun 20;17(7):803. doi: 10.3390/pharmaceutics17070803.

DOI:10.3390/pharmaceutics17070803
PMID:40733013
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12300936/
Abstract

mRNA-based drug development is revolutionizing tumor therapies by enabling precise cancer immunotherapy, tumor suppressor gene restoration, and genome editing. However, the success of mRNA therapies hinges on efficient delivery systems that can protect mRNA from degradation and facilitate its release into the cytoplasm for translation. Despite the emergence of lipid nanoparticles (LNPs) as a clinically advanced platform for mRNA delivery, the efficiency of endo/lysosomal escape still represents a substantial bottleneck. Here, we summarize the intracellular fate of mRNA-loaded LNPs, focusing on their internalization pathways and processing within the endo-lysosomal system. We also discuss the impact of endo-lysosomal processes on mRNA delivery and explore potential strategies to improve mRNA escape from endo-lysosomal compartments. This review focuses on molecular engineering strategies to enhance LNP-mediated endo/lysosomal escape by optimizing lipid composition, including ionizable lipids, helper lipids, cholesterol, and PEGylated lipids. Additionally, ancillary enhancement strategies such as surface coating and shape management are discussed. By comprehensively integrating mechanistic insights into the journey of LNPs within the endo-lysosome system and recent advances in lipid chemistry, this review offers valuable inspiration for advancing mRNA-based cancer therapies by enabling robust protein expression.

摘要

基于信使核糖核酸(mRNA)的药物开发正在彻底改变肿瘤治疗方法,实现精确的癌症免疫治疗、肿瘤抑制基因恢复和基因组编辑。然而,mRNA疗法的成功取决于高效的递送系统,该系统能够保护mRNA不被降解,并促进其释放到细胞质中进行翻译。尽管脂质纳米颗粒(LNPs)作为一种临床先进的mRNA递送平台已经出现,但内体/溶酶体逃逸效率仍然是一个重大瓶颈。在这里,我们总结了负载mRNA的LNPs的细胞内命运,重点关注它们的内化途径和在内体-溶酶体系统中的处理过程。我们还讨论了内体-溶酶体过程对mRNA递送的影响,并探索改善mRNA从内体-溶酶体区室逃逸的潜在策略。本综述重点关注通过优化脂质组成(包括可电离脂质、辅助脂质、胆固醇和聚乙二醇化脂质)来增强LNP介导的内体/溶酶体逃逸的分子工程策略。此外,还讨论了诸如表面涂层和形状管理等辅助增强策略。通过将机制见解全面整合到LNPs在内体-溶酶体系统中的旅程以及脂质化学的最新进展,本综述为通过实现强大的蛋白质表达推进基于mRNA的癌症治疗提供了宝贵的灵感。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96d4/12300936/e810b1aede27/pharmaceutics-17-00803-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96d4/12300936/718a4f05d2da/pharmaceutics-17-00803-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96d4/12300936/73ceac519b94/pharmaceutics-17-00803-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96d4/12300936/e810b1aede27/pharmaceutics-17-00803-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96d4/12300936/718a4f05d2da/pharmaceutics-17-00803-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96d4/12300936/73ceac519b94/pharmaceutics-17-00803-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96d4/12300936/e810b1aede27/pharmaceutics-17-00803-g003.jpg

相似文献

1
Endo/Lysosomal-Escapable Lipid Nanoparticle Platforms for Enhancing mRNA Delivery in Cancer Therapy.用于增强癌症治疗中mRNA递送的可逃逸至内体/溶酶体的脂质纳米颗粒平台
Pharmaceutics. 2025 Jun 20;17(7):803. doi: 10.3390/pharmaceutics17070803.
2
Lipid nanoparticle mediated mRNA delivery in cancer immunotherapy.脂质纳米颗粒介导的mRNA递送在癌症免疫治疗中的应用
Adv Immunol. 2025;166:37-75. doi: 10.1016/bs.ai.2025.02.001. Epub 2025 Mar 5.
3
Nucleic Acid Nanocapsules as a New Platform to Deliver Therapeutic Nucleic Acids for Gene Regulation.核酸纳米胶囊作为用于基因调控的治疗性核酸递送新平台。
Acc Chem Res. 2025 Jul 1;58(13):1951-1962. doi: 10.1021/acs.accounts.5c00126. Epub 2025 Jun 9.
4
Lipid Nanoparticle-Associated Inflammation is Triggered by Sensing of Endosomal Damage: Engineering Endosomal Escape Without Side Effects.脂质纳米颗粒相关的炎症是由内体损伤的感知引发的:设计无副作用的内体逃逸。
bioRxiv. 2024 Apr 18:2024.04.16.589801. doi: 10.1101/2024.04.16.589801.
5
Impact of ionizable lipid type on the pharmacokinetics and biodistribution of mRNA-lipid nanoparticles after intravenous and subcutaneous injection.可电离脂质类型对静脉注射和皮下注射后mRNA-脂质纳米颗粒的药代动力学和生物分布的影响。
J Control Release. 2025 Aug 10;384:113945. doi: 10.1016/j.jconrel.2025.113945. Epub 2025 Jun 10.
6
Tryptophan and IFN-γ Differentially Modulate Cellular Uptake, Intracellular Trafficking, and Gene Expression of Messenger RNA-Loaded Lipid Nanoparticles in Dendritic Cells.色氨酸和干扰素-γ对树突状细胞中信使核糖核酸负载脂质纳米颗粒的细胞摄取、细胞内运输及基因表达具有不同调节作用。
bioRxiv. 2025 Jul 13:2025.07.10.664160. doi: 10.1101/2025.07.10.664160.
7
A perspective on the apparent pKa of ionizable lipids in mRNA-LNPs.关于mRNA脂质纳米颗粒中可电离脂质表观pKa的观点。
J Control Release. 2025 Aug 10;384:113879. doi: 10.1016/j.jconrel.2025.113879. Epub 2025 May 21.
8
Engineered lipid nanoparticles with synergistic dendritic cell targeting and enhanced endosomal escape for boosted mRNA cancer vaccines.具有协同树突状细胞靶向作用和增强内体逃逸能力的工程化脂质纳米颗粒,用于增强型mRNA癌症疫苗。
Mater Today Bio. 2025 Jul 19;34:102107. doi: 10.1016/j.mtbio.2025.102107. eCollection 2025 Oct.
9
Efficacy versus immunogenicity of LNP-mediated delivery of mRNA and self-amplifying RNA upon intravitreal injection in the mouse eye.脂质纳米颗粒介导的mRNA和自扩增RNA玻璃体内注射到小鼠眼中后的疗效与免疫原性
J Control Release. 2025 Jul 12;385:114027. doi: 10.1016/j.jconrel.2025.114027.
10
The impact of lipid compositions on siRNA and mRNA lipid nanoparticle performance for pulmonary delivery.脂质组成对用于肺部递送的小干扰RNA(siRNA)和信使核糖核酸(mRNA)脂质纳米颗粒性能的影响。
Eur J Pharm Sci. 2025 Jun 24:107182. doi: 10.1016/j.ejps.2025.107182.

本文引用的文献

1
Lipid-siRNA Organization Modulates the Intracellular Dynamics of Lipid Nanoparticles.脂质-小干扰RNA的组织方式调节脂质纳米颗粒的细胞内动力学。
J Am Chem Soc. 2025 Mar 26;147(12):10430-10445. doi: 10.1021/jacs.4c18308. Epub 2025 Mar 11.
2
Advancing endosomal escape of polymeric nanoparticles: towards improved intracellular delivery.促进聚合物纳米颗粒的内体逃逸:迈向改善细胞内递送
Mater Horiz. 2025 Jun 3;12(11):3622-3632. doi: 10.1039/d4mh01781a.
3
Cubic Phase-Inducible Zwitterionic Phospholipids Improve the Functional Delivery of mRNA.
立方相诱导两性离子磷脂改善mRNA的功能性递送
Adv Sci (Weinh). 2025 May;12(17):e2413016. doi: 10.1002/advs.202413016. Epub 2025 Feb 17.
4
Coordination between ESCRT function and Rab conversion during endosome maturation.内体成熟过程中ESCRT功能与Rab转换之间的协调。
EMBO J. 2025 Mar;44(6):1574-1607. doi: 10.1038/s44318-025-00367-7. Epub 2025 Feb 5.
5
The therapeutic potential of circular RNAs.环状RNA的治疗潜力。
Nat Rev Genet. 2025 Apr;26(4):230-244. doi: 10.1038/s41576-024-00806-x. Epub 2025 Jan 9.
6
Lysosomal damage due to cholesterol accumulation triggers immunogenic cell death.胆固醇积累导致的溶酶体损伤引发免疫原性细胞死亡。
Autophagy. 2025 May;21(5):934-956. doi: 10.1080/15548627.2024.2440842. Epub 2024 Dec 27.
7
Corosolic acid derivative-based lipid nanoparticles for efficient RNA delivery.基于科罗索酸衍生物的脂质纳米颗粒用于高效RNA递送。
J Control Release. 2025 Feb 10;378:1-17. doi: 10.1016/j.jconrel.2024.11.073. Epub 2024 Dec 7.
8
Multiple tail ionizable lipids improve in vivo mRNA delivery efficiency with biosafety.多尾可离子化脂质可提高体内 mRNA 递送效率并保证生物安全性。
Int J Pharm. 2024 Dec 25;667(Pt A):124868. doi: 10.1016/j.ijpharm.2024.124868. Epub 2024 Oct 24.
9
Enhancing Cytoplasmic Expression of Exogenous mRNA Through Dynamic Mechanical Stimulation.通过动态机械刺激增强外源mRNA的细胞质表达
Adv Healthc Mater. 2025 Jan;14(1):e2401918. doi: 10.1002/adhm.202401918. Epub 2024 Oct 23.
10
PEGylation-Dependent Cell Uptake of Lipid Nanoparticles Revealed by Spatiotemporal Correlation Spectroscopy.时空相关光谱揭示的聚乙二醇化对脂质纳米颗粒细胞摄取的影响
ACS Pharmacol Transl Sci. 2024 Sep 5;7(10):3004-3010. doi: 10.1021/acsptsci.4c00419. eCollection 2024 Oct 11.